Medistim ASA (OSL:MEDI)
Norway
· Delayed Price · Currency is NOK 228.00
-2.00 (-0.87%)
Apr 29, 2026, 4:25 PM CET
Medistim ASA Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 159.21 | 103.83 | 103.82 | 113.97 | 90.9 | Upgrade
|
| Depreciation & Amortization | 16.02 | 15.4 | 23.66 | 23.29 | 23.43 | Upgrade
|
| Other Operating Activities | 19.3 | 2 | 5.69 | 12.91 | 9.83 | Upgrade
|
| Change in Accounts Receivable | -17.41 | 5.32 | 27.35 | -33.02 | -11.15 | Upgrade
|
| Change in Inventory | -0.61 | -15.13 | -31.06 | -16.92 | 15.25 | Upgrade
|
| Change in Accounts Payable | 8.9 | 1.95 | 0.61 | 11.27 | -0.32 | Upgrade
|
| Change in Other Net Operating Assets | 1.68 | 29.73 | -10.88 | 2 | -0.57 | Upgrade
|
| Operating Cash Flow | 187.08 | 143.1 | 119.2 | 113.49 | 127.37 | Upgrade
|
| Operating Cash Flow Growth | 30.73% | 20.06% | 5.03% | -10.90% | 71.82% | Upgrade
|
| Capital Expenditures | -5.49 | -6.07 | -16.4 | -9.25 | -7.4 | Upgrade
|
| Sale (Purchase) of Intangibles | -27.52 | -18.63 | -13.33 | -11.85 | -4.08 | Upgrade
|
| Investing Cash Flow | -33.01 | -24.69 | -29.73 | -21.1 | -11.49 | Upgrade
|
| Long-Term Debt Repaid | -9.36 | -9.12 | -8.71 | -7.31 | -12 | Upgrade
|
| Net Debt Issued (Repaid) | -9.36 | -9.12 | -8.71 | -7.31 | -12 | Upgrade
|
| Repurchase of Common Stock | -4.65 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -109.47 | -82.41 | -82.18 | -68.4 | -54.64 | Upgrade
|
| Other Financing Activities | - | - | - | 5.4 | 7.59 | Upgrade
|
| Financing Cash Flow | -123.48 | -91.53 | -90.89 | -70.3 | -59.05 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.28 | -1.54 | 2.65 | 1.07 | 0.76 | Upgrade
|
| Net Cash Flow | 32.88 | 25.34 | 1.23 | 23.15 | 57.6 | Upgrade
|
| Free Cash Flow | 181.59 | 137.04 | 102.8 | 104.24 | 119.97 | Upgrade
|
| Free Cash Flow Growth | 32.51% | 33.30% | -1.38% | -13.11% | 79.91% | Upgrade
|
| Free Cash Flow Margin | 25.95% | 24.36% | 19.73% | 21.44% | 28.71% | Upgrade
|
| Free Cash Flow Per Share | 9.94 | 7.48 | 5.62 | 5.70 | 6.57 | Upgrade
|
| Cash Income Tax Paid | 28.34 | 28.4 | 25.7 | 19.17 | 13.34 | Upgrade
|
| Levered Free Cash Flow | 123.13 | 72.36 | 64.81 | 56.39 | 98.98 | Upgrade
|
| Unlevered Free Cash Flow | 123.47 | 72.56 | 64.81 | 56.47 | 99.09 | Upgrade
|
| Change in Working Capital | -7.44 | 21.88 | -13.97 | -36.68 | 3.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.